Next Article in Journal
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial
Previous Article in Journal
A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins
Previous Article in Special Issue
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin
 
 
Review

Article Versions Notes

Viruses 2022, 14(3), 613; https://doi.org/10.3390/v14030613
Action Date Notes Link
article xml file uploaded 15 March 2022 14:17 CET Original file -
article xml uploaded. 15 March 2022 14:17 CET Update https://www.mdpi.com/1999-4915/14/3/613/xml
article pdf uploaded. 15 March 2022 14:17 CET Version of Record https://www.mdpi.com/1999-4915/14/3/613/pdf
article html file updated 15 March 2022 14:18 CET Original file -
article html file updated 1 August 2022 05:49 CEST Update https://www.mdpi.com/1999-4915/14/3/613/html
Back to TopTop